TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04015258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00713011 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01802931 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03489317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03030378 — Safety Biomarker (SAF): Interleukin 12
Study NCT00427700 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03332030 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05072899 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01530958 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01350323 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01350323 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02654730 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT02276820 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01730430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03279952 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study NCT02964364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02964364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02845856 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04366882 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04366882 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study NCT03719391 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT00005315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02457507 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00158587 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04035226 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00410124 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01026233 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04174495 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04436744 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04436744 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01816984 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01816984 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00874601 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03260712 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT03549962 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00678522 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01802632 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02636010 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00484575 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01783977 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02445209 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03627702 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT00158093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03123653 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04312022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04476745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00256243 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03709446 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03709446 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT03709446 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04188028 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03402841 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT03615885 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01152437 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01152437 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01152437 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01105572 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02217969 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04466891 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04466891 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00027560 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT05255718 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04658615 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04340362 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT00612001 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03670472 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04378153 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03827317 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03800355 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02703740 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01547741 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03276039 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT04282980 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT01674270 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02765373 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02765373 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01393912 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02448420 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02448420 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02448420 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02448420 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03860220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02347163 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02347163 — Predictive Biomarker (PRD): WWTR1 mRNA
Genes: WWTR1; TAZ
Study NCT02347163 — Predictive Biomarker (PRD): PIN1 mRNA
Genes: PIN1
Study NCT02983799 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT01417884 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02511639 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02511639 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03775369 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01646775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01646775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01646775 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02369536 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT04542681 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02854163 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT02796456 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study NCT03641287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02077127 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01668680 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01668680 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT00557193 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00005267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03963284 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT03963284 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00202358 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00470015 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00004157 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00004157 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT01650402 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01544140 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04079335 — Safety Biomarker (SAF): Bacteroidetes phylum
Study NCT03007147 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02063256 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01185522 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00092599 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03702400 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00186459 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03937661 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT01006395 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01552018 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04582344 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03051191 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04641832 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT04641832 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT00773084 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00724763 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02566863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01738243 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04397692 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06553040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04017130 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04475224 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02138331 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00321568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00942058 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT00942058 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04490681 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03178396 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04063813 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04431934 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT03810976 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03454893 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT03454893 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT01678521 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT00652119 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00001318 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01524536 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03914534 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02683889 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03999372 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01442987 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03695445 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03651206 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01349114 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02261688 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02261688 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT00620217 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00620217 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01535989 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02023554 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02829372 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00213642 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT00213642 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01187576 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03601351 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study NCT01493544 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study NCT04348474 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03758651 — Predictive Biomarker (PRD): AWAT2 mRNA
Genes: AWAT2; DC4; DGAT2L4; MFAT; WS
Study NCT03758651 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03758651 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00344019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01701882 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00462826 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00071955 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03114020 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01744015 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT02755961 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02350452 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04454892 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00250562 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02957630 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02458599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04767828 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04555954 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03516721 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04510207 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01340456 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01731561 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00775957 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03914170 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03914170 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03694678 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT00696605 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02328872 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03448211 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT02209740 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04089488 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00374699 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT04628442 — Predictive Biomarker (PRD): ACRC mRNA
Genes: GCNA; ACRC
Study NCT03884855 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT01596504 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00395018 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00530842 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00866554 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00738296 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02524288 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT02971501 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06128876 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT03108196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03209258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02614820 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01110850 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT02040935 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00414206 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04480814 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04480814 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT00529633 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00529633 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00233519 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT00719823 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01219257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00001561 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02443935 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT03537443 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00060099 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02951260 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT03986957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02447185 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02447185 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03059264 — Predictive Biomarker (PRD): DMPK mRNA
Genes: DMPK; DM1PK; MDPK
Study NCT00340080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT04442269 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04442269 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01935453 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04272697 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04272697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01758094 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT01196715 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02313090 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02313090 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02146924 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02146924 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02146924 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04686981 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT01863212 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT04293562 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01381185 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00019669 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02803606 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03899480 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01944410 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02599844 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05311397 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04633330 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00361517 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01599286 — Safety Biomarker (SAF): Carbamoyl-phosphate synthetase I
Genes: CPS1
Study NCT01599286 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT02030028 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00772759 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01956669 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00076986 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT00298376 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03997032 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04925141 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02808442 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02375581 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1